TickerFacts.

Prelude Therapeutics Inc (PRLD): Depreciation & Amortization

Annual figures by period end, from SEC filings.

$1.71M
Year ended 2025-12-31
$1.59M
Trailing 12 months to 2026-06-30
+8.9%
3-year compound annual growth
+25.8%
5-year compound annual growth
$1.77M2019-12-31: $382.0K2020-12-31: $542.0K2021-12-31: $915.0K2022-12-31: $1.32M2023-12-31: $1.17M2024-12-31: $1.77M2025-12-31: $1.71M$1.71M
2019-12-31 Depreciation & Amortization (USD) 2025-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2025-12-31$1.71M-3.4%2026-03-10, From 2025-01-01
2024-12-31$1.77M+51.6%2026-03-10, From 2024-01-01
2023-12-31$1.17M-11.7%2025-03-10, From 2023-01-01
2022-12-31$1.32M+44.7%2024-02-15, From 2022-01-01
2021-12-31$915.0K+68.8%2023-03-15, From 2021-01-01
2020-12-31$542.0K+41.9%2022-03-17, From 2020-01-01
2019-12-31$382.0Kn/a2021-03-16, From 2019-01-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedDepreciation & AmortizationChange YoY
Prelude Therapeutics Inc (PRLD)2025-12-31$1.71M-3.4%
Emmaus Life Sciences, Inc. (EMMA)2025-12-31$39.0K+77.3%
Jaguar Health, Inc. (JAGX)2025-12-31$1.91M+0.7%
Evommune, Inc. (EVMN)2025-12-31$600.0K+20.0%
Tonix Pharmaceuticals Holding Corp. (TNXP)2025-12-31$1.90M-34.5%
CV Sciences, Inc. (CVSI)2025-12-31$192.0K-42.5%
Pyxis Oncology, Inc. (PYXS)2025-12-31$4.51M+51.3%
Precigen, Inc. (PGEN)2025-12-31$3.20M-29.3%
Prothena Corp Public Ltd Co (PRTA)2025-12-31$895.0K+0.2%

Compare PRLD, EMMA, JAGX, EVMN side by side · Screen every company in Pharmaceutical Preparations ↗